Similar to in vitro observation, ERS inhibition and SSTA led to significant tumor shrinkage and slower tumor growth (Fig. 2d, Fig. S2d-S2e), as well as a greater decrease of GH release (Fig. 2e). Here, GH1 is linked to neoplasm.